JNCCN 360 - Non-Melanoma Skin Cancers

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Francis P. Worden, MD, on Vismodegib: Organ Preservation for Orbital/Periocular Basal Cell Carcinoma

Danny Rischin, MD, on Cutaneous Squamous Cell Carcinoma: Follow-up Data on Cemiplimab

Nikolaos Andreatos, MD, on Adverse Events Following Radiotherapy and Immunotherapy in Patients With Melanoma and Merkel Cell Carcinoma

Recent

Perineural Invasion in Basal Cell Carcinoma

KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma

Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies

Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna

Published

Medical Literature

Merkel Cell Carcinoma: Do Women Have Better Outcomes Than Men?

Cisplatin Electrochemotherapy for Small Non‐Melanoma Skin Lesions

Antimalaria Drug May Inhibit Virus-Positive Merkel Cell Carcinoma Growth

Multidisciplinary Approaches to Managing Merkel Cell Carcinoma

Ongoing

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

Available

Clinical Trials

University of Wisconsin Carbone Cancer Center

University of California San Diego Moores Cancer Center

The Ohio State University Comprehensive Cancer Center

Fox Chase Cancer Center

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.